tiprankstipranks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market
Holding AU:RAD?
Track your performance easily

Radiopharm Theranostics Limited (RAD) Income Statement

13 Followers

Radiopharm Theranostics Limited Income Statement

Last quarter (Q4 2022), Radiopharm Theranostics Limited's total revenue was $―. In Q4, Radiopharm Theranostics Limited's net income was $―. See Radiopharm Theranostics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
$ 8.83K
Cost of Revenue
$ ―
Gross Profit
$ 8.83K
Operating Expense
$ 19.93M
Operating Income
$ -19.92M
Net Non Operating Interest Income Expense
$ -9.35M
Other Income Expense
$ -1.03M
Pretax Income
$ -30.29M
Tax Provision
$ 44.40K
Earnings From Equity Interest Net Of Tax
$ ―
Net Income Common Stockholders
$ -30.34M
Basic EPS
$ -0.16
Diluted EPS
$ -0.16
Basic Average Shares
$ 187.49M
Diluted Average Shares
$ 187.49M
Dividend Per Share
$ ―
Total Operating Income As Reported
$ ―
Reported Normalized Basic E P S
$ ―
Reported Normalized Diluted E P S
$ ―
Rent Expense Supplemental
$ ―
Total Expenses
$ ―
Net Income From Continuing And Discontinued Operation
$ -30.34M
Normalized Income
$ -30.34M
Interest Expense
$ 9.35M
EBIT
$ -20.94M
EBITDA
$ -17.96M
Currency in USD

Radiopharm Theranostics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis